Egyptian MP Irene Said emphasises the importance of maintaining quality and patient access amid plans to expand domestic pharmaceutical manufacturing, highlighting concerns over treatment suitability and supply reliability. Egyptian lawmaker Irene Said has urged caution over plans to expand local…
A recent retrospective study suggests that SGLT2 inhibitors may be associated with a reduced risk of dementia in adults with type 2 diabetes and a history of traumatic brain injury, prompting calls for further research. A class of diabetes medicines…
A new study suggests that starting SGLT2 inhibitors for adults with type 2 diabetes and a history of traumatic brain injury may lower the risk of developing dementia, marking a potential shift in neuroprotective strategies in complex diabetes care. In…
A recent case highlights the silent progression of diabetic retinopathy and underscores the importance of regular eye screenings and blood sugar control to prevent irreversible vision loss. Diabetic retinopathy is one of diabetes’s quietest dangers: it can damage the retina…
Venezuela’s health watchdog issues alert against unauthorised Glyxon tablets falsely marketed for treating chronic metabolic diseases, amid a global surge in illegal and counterfeit medicines for diabetes and weight loss. Venezuela’s autonomous health watchdog has warned against what it described…
Women’s premenstrual symptoms may be amplified by hormone-induced blood sugar swings, with implications for managing cravings, energy, and metabolic health across the cycle. The days before a period can bring more than cramps and mood swings. For many women, they…
New research reveals that hormonal shifts during the menstrual cycle can significantly affect blood glucose and appetite, highlighting the need for tailored management for women with metabolic conditions. The week before a period can bring more than mood swings and…
New research highlights how hormonal shifts during the menstrual cycle can impact blood sugar regulation, especially in women with prediabetes, diabetes, or PCOS, prompting calls for cycle-aware monitoring. For many women, the days before a period bring a familiar mix…
A large observational study indicates tirzepatide could offer superior outcomes over dulaglutide for patients with heart failure with preserved ejection fraction, sparking interest in further clinical trials. A large real-world study has found tirzepatide was associated with better outcomes than…
The UK has approved orforglipron, a new once-daily oral medication for weight management and type 2 diabetes, marking a first in Europe. The drug offers a convenient alternative to existing treatments and is subject to NHS evaluation before wider availability.…
